Direkt zum Inhalt
Merck

Pyridoxine hydrochloride treatment of carpal tunnel syndrome: a review.

Nutrition reviews (2004-04-22)
Elaine Aufiero, Todd P Stitik, Patrick M Foye, Boqing Chen
ZUSAMMENFASSUNG

It has been hypothesized that idiopathic carpal tunnel syndrome (CTS) is a manifestation of vitamin B6 deficiency. Some claim that B6 supplementation can alleviate symptoms. Others argue that pain relief occurs because of vitamin B6's anti-nociceptive properties or because B6 supplementation addresses an unrecognized peripheral neuropathy. Few studies on CTS and B6 employed electrodiagnostic techniques in diagnosis, and few showed a correlation between symptoms and improved electrodiagnostic parameters with supplementation. Other studies failed to measure or estimate B6 levels. Nevertheless, it appears reasonable to recommend vitamin B6 supplementation to people with CTS. Some patients will improve symptomatically with low risks of toxicity in recommended doses.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Pyridoxin -hydrochlorid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture
Sigma-Aldrich
Pyridoxin, ≥98%
Supelco
Pyridoxinhydrochlorid (B6), analytical standard
Supelco
Pyridoxin -hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Pyridoxin -hydrochlorid, ≥98% (HPLC)
USP
Pyridoxin -hydrochlorid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Pyridoxin -hydrochlorid, meets USP testing specifications
Pyridoxin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard